Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionGlenmede Trust Co Na
Latest Disclosed Ownership1,150,414 shares
Latest Disclosed Value $ 4,601,656
Glenmede Trust Co Na reports 3.69% increase in ownership of 9EH / Evolent Health, Inc.

On February 17, 2026 - Glenmede Trust Co Na filed a 13F-HR form disclosing ownership of 1,150,414 shares of Evolent Health, Inc. (DE:9EH) valued at $3,934,416 USD as of December 31, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 1,109,427 shares of Evolent Health, Inc.. This represents a change in shares of 3.69% during the quarter. The current value of the position is $3,888,399 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 1,150,414 40,987 3.69 4,602 -56.21 0.0099
2025-05-15 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 1,109,427 605,831 120.30 10,506 85.45 0.0564
2025-02-14 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 503,596 -227 -0.05 5,665 -60.24 0.0289
2024-11-13 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 503,823 -112 -0.02 14,248 47.88 0.0681
2024-08-14 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 503,935 2,945 0.59 9,635 -41.35 0.0489
2024-05-15 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 500,990 34,066 7.30 16,427 6.52 0.0824
2024-02-13 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 466,924 -11,888 -2.48 15,422 18.29 0.0800
2023-11-14 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 478,812 -5,388 -1.11 13,038 -16.69 0.0745
2023-08-14 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 484,200 952 0.20 15,650 -0.20 0.0888
2023-05-15 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 483,248 5,291 1.11 15,681 16.84 0.0890
2023-02-14 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 477,957 -62,674 -11.59 13,421 -30.90 0.0787
2022-11-16 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 540,631 -287,829 -34.74 19,423 -23.65 0.1224
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 828,460 -90,650 -9.86 25,441 -14.30 0.1491
2022-05-16 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 919,110 -9,295 -1.00 29,686 15.56 0.1457
2022-02-15 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 928,405 -7,258 -0.78 25,688 -11.44 0.1220
2021-11-15 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 935,663 -11,500 -1.21 29,005 45.00 0.1503
2021-08-16 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 947,163 -2,241 -0.24 20,004 4.31 0.1035
2021-05-18 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 949,404 -249,844 -20.83 19,178 -0.23 0.1034
2021-02-16 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 1,199,248 -91,833 -7.11 19,223 19.99 0.1057
2020-11-16 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 1,291,081 -203,708 -13.63 16,021 50.53 0.0960
2020-08-14 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 1,494,789 -802,223 -34.92 10,643 -48.80 0.0651
2020-05-20 2020-03-31 13F EVOLENT HEALTH INC CL A COMMON 30050B101 2,297,012 0 0.00 20,787 0.00 0.0948
2020-02-12 2019-12-31 13F EVOLENT HEALTH INC CL A COMMON 30050B101 2,297,012 -270,222 -10.53 20,787 12.62 0.0948
2019-11-14 2019-09-30 13F EVOLENT HEALTH INC CL A COMMON 30050B101 2,567,234 -198,167 -7.17 18,458 -16.04 0.0844
2019-08-13 2019-06-30 13F EVOLENT HEALTH INC CL A COMMON 30050B101 2,765,401 2,765,281 2,304,400.83 21,984 2,198,300.00 0.0965
2019-05-14 2019-03-31 13F EVOLENT HEALTH INC CL A COMMON 30050B101 120 -424 -77.94 1 -90.00 0.0000
2019-02-14 2018-12-31 13F EVOLENT HEALTH INC CL A COMMON 30050B101 544 544 10 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.